444 related articles for article (PubMed ID: 12297057)
21. [Early bronchial inflammation in cystic fibrosis].
Puchelle E
J Soc Biol; 2002; 196(1):29-35. PubMed ID: 12134630
[TBL] [Abstract][Full Text] [Related]
22. Losartan Rescues Inflammation-related Mucociliary Dysfunction in Relevant Models of Cystic Fibrosis.
Kim MD; Baumlin N; Yoshida M; Polineni D; Salathe SF; David JK; Peloquin CA; Wanner A; Dennis JS; Sailland J; Whitney P; Horrigan FT; Sabater JR; Abraham WM; Salathe M
Am J Respir Crit Care Med; 2020 Feb; 201(3):313-324. PubMed ID: 31613648
[No Abstract] [Full Text] [Related]
23. Mucociliary Transport in Healthy and Cystic Fibrosis Pig Airways.
Xie Y; Ostedgaard L; Abou Alaiwa MH; Lu L; Fischer AJ; Stoltz DA
Ann Am Thorac Soc; 2018 Nov; 15(Suppl 3):S171-S176. PubMed ID: 30431346
[TBL] [Abstract][Full Text] [Related]
24. Cellular and molecular architecture of submucosal glands in wild-type and cystic fibrosis pigs.
Yu W; Moninger TO; Thurman AL; Xie Y; Jain A; Zarei K; Powers LS; Pezzulo AA; Stoltz DA; Welsh MJ
Proc Natl Acad Sci U S A; 2022 Jan; 119(4):. PubMed ID: 35046051
[TBL] [Abstract][Full Text] [Related]
25. Treatment of cystic fibrosis airway cells with CFTR modulators reverses aberrant mucus properties
Morrison CB; Shaffer KM; Araba KC; Markovetz MR; Wykoff JA; Quinney NL; Hao S; Delion MF; Flen AL; Morton LC; Liao J; Hill DB; Drumm ML; O'Neal WK; Kesimer M; Gentzsch M; Ehre C
Eur Respir J; 2022 Feb; 59(2):. PubMed ID: 34172469
[TBL] [Abstract][Full Text] [Related]
26. Acid exposure disrupts mucus secretion and impairs mucociliary transport in neonatal piglet airways.
Liao YSJ; Kuan SP; Guevara MV; Collins EN; Atanasova KR; Dadural JS; Vogt K; Schurmann V; Bravo L; Eken E; Sponchiado M; Reznikov LR
Am J Physiol Lung Cell Mol Physiol; 2020 May; 318(5):L873-L887. PubMed ID: 32160007
[TBL] [Abstract][Full Text] [Related]
27. Acidic pH increases airway surface liquid viscosity in cystic fibrosis.
Tang XX; Ostedgaard LS; Hoegger MJ; Moninger TO; Karp PH; McMenimen JD; Choudhury B; Varki A; Stoltz DA; Welsh MJ
J Clin Invest; 2016 Mar; 126(3):879-91. PubMed ID: 26808501
[TBL] [Abstract][Full Text] [Related]
28. Physical and functional properties of airway secretions in cystic fibrosis--therapeutic approaches.
Puchelle E; de Bentzmann S; Zahm JM
Respiration; 1995; 62 Suppl 1():2-12. PubMed ID: 7792436
[TBL] [Abstract][Full Text] [Related]
29. Mucous hypersecretion and relationship to cough.
Nadel JA
Pulm Pharmacol Ther; 2013 Oct; 26(5):510-3. PubMed ID: 23434445
[TBL] [Abstract][Full Text] [Related]
30. SPX-101 Is a Novel Epithelial Sodium Channel-targeted Therapeutic for Cystic Fibrosis That Restores Mucus Transport.
Scott DW; Walker MP; Sesma J; Wu B; Stuhlmiller TJ; Sabater JR; Abraham WM; Crowder TM; Christensen DJ; Tarran R
Am J Respir Crit Care Med; 2017 Sep; 196(6):734-744. PubMed ID: 28481660
[TBL] [Abstract][Full Text] [Related]
31. Mucins, mucus, and sputum.
Voynow JA; Rubin BK
Chest; 2009 Feb; 135(2):505-512. PubMed ID: 19201713
[TBL] [Abstract][Full Text] [Related]
32. Critical role of cytosolic phospholipase A2{alpha} in bronchial mucus hypersecretion in CFTR-deficient mice.
Dif F; Wu YZ; Burgel PR; Ollero M; Leduc D; Aarbiou J; Borot F; Garcia-Verdugo I; Martin C; Chignard M; Israel-Biet D; Kita Y; Scholte BJ; Touqui L
Eur Respir J; 2010 Nov; 36(5):1120-30. PubMed ID: 20413542
[TBL] [Abstract][Full Text] [Related]
33. Role of CFTR in airway disease.
Pilewski JM; Frizzell RA
Physiol Rev; 1999 Jan; 79(1 Suppl):S215-55. PubMed ID: 9922383
[TBL] [Abstract][Full Text] [Related]
34. Airway surface liquid homeostasis in cystic fibrosis: pathophysiology and therapeutic targets.
Haq IJ; Gray MA; Garnett JP; Ward C; Brodlie M
Thorax; 2016 Mar; 71(3):284-7. PubMed ID: 26719229
[TBL] [Abstract][Full Text] [Related]
35. Bicarbonate in cystic fibrosis.
Kunzelmann K; Schreiber R; Hadorn HB
J Cyst Fibros; 2017 Nov; 16(6):653-662. PubMed ID: 28732801
[TBL] [Abstract][Full Text] [Related]
36. The mucus bundles responsible for airway cleaning are retained in cystic fibrosis and by cholinergic stimulation.
Ermund A; Meiss LN; Dolan B; Bähr A; Klymiuk N; Hansson GC
Eur Respir J; 2018 Aug; 52(2):. PubMed ID: 29853489
[TBL] [Abstract][Full Text] [Related]
37. Cystic Fibrosis Lung Disease: An Overview.
Turcios NL
Respir Care; 2020 Feb; 65(2):233-251. PubMed ID: 31772069
[TBL] [Abstract][Full Text] [Related]
38. Cystic Fibrosis: Pathophysiology of Lung Disease.
Bergeron C; Cantin AM
Semin Respir Crit Care Med; 2019 Dec; 40(6):715-726. PubMed ID: 31659725
[TBL] [Abstract][Full Text] [Related]
39. Anti-inflammatories and mucociliary clearance therapies in the age of CFTR modulators.
Perrem L; Ratjen F
Pediatr Pulmonol; 2019 Nov; 54 Suppl 3():S46-S55. PubMed ID: 31715088
[TBL] [Abstract][Full Text] [Related]
40. Electrolyte transport properties in distal small airways from cystic fibrosis pigs with implications for host defense.
Li X; Tang XX; Vargas Buonfiglio LG; Comellas AP; Thornell IM; Ramachandran S; Karp PH; Taft PJ; Sheets K; Abou Alaiwa MH; Welsh MJ; Meyerholz DK; Stoltz DA; Zabner J
Am J Physiol Lung Cell Mol Physiol; 2016 Apr; 310(7):L670-9. PubMed ID: 26801568
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
